Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.

Newland-Jones P, Kar P, Kelly B, Mohan R, Davies S, Diggle J, Evans M, Fernando K, Hicks D, Kanumilli N, Milne N, Patel D, Seidu S, Viljoen A, Wheeler DC, Wilding JPH

Open source

DOI: 10.1007/s13300-026-01889-x
Published: 2026 Aug
Container: Diabetes therapy : research, treatment and education of diabetes and related disorders
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13300-026-01889-x,
  title = {Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.},
  author = {Newland-Jones P and Kar P and Kelly B and Mohan R and Davies S and Diggle J and Evans M and Fernando K and Hicks D and Kanumilli N and Milne N and Patel D and Seidu S and Viljoen A and Wheeler DC and Wilding JPH},
  year = {2026},
  journal = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
  doi = {10.1007/s13300-026-01889-x},
  url = {https://doi.org/10.1007/s13300-026-01889-x}
}

RIS

TY  - JOUR
TI  - Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.
AU  - Newland-Jones P
AU  - Kar P
AU  - Kelly B
AU  - Mohan R
AU  - Davies S
AU  - Diggle J
AU  - Evans M
AU  - Fernando K
AU  - Hicks D
AU  - Kanumilli N
AU  - Milne N
AU  - Patel D
AU  - Seidu S
AU  - Viljoen A
AU  - Wheeler DC
AU  - Wilding JPH
PY  - 2026
JO  - Diabetes therapy : research, treatment and education of diabetes and related disorders
DO  - 10.1007/s13300-026-01889-x
UR  - https://doi.org/10.1007/s13300-026-01889-x
ER  -

APA

P, N., P, K., B, K., R, M., S, D., J, D., M, E., K, F., D, H., N, K., N, M., D, P., S, S., A, V., DC, W., & JPH, W. (2026). Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.. Diabetes therapy : research, treatment and education of diabetes and related disorders. https://doi.org/10.1007/s13300-026-01889-x

Source records

pubmed · retrieved 2026-09-26T04:17:32.979Z
europe-pmc · retrieved 2026-09-26T04:17:32.994Z